Identification of expression profiles and transcription factors during EGFR‐TKI acquired resistance in LUAD
Abstract Lung cancer is one of the most‐common malignant tumors while lung adenocarcinoma (LUAD) serves as the major subtype of lung cancer. The epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKIs) are an important choice in LUAD targeted therapies. However, EGFR‐TKI acquired resi...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Precision Medical Sciences |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/prm2.12146 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|